
October 22, 2026 – Shares of clinical-stage biopharmaceutical enterprise Veradermics Incorporated surged to fresh record highs during Thursday premarket trading, hovering near 136.27 USD on the New York Stock Exchange.The Connecticut-based…
BMV
Delayed Data
Nov 20, 2025, 02:30 PM
Day's Range
68.0052 wk Range
26.40
October 22, 2026 – Shares of clinical-stage biopharmaceutical enterprise Veradermics Incorporated surged to fresh record highs during Thursday premarket trading, hovering near 136.27 USD on the New York Stock Exchange.The Connecticut-based…

October 22, 2026 – Clinical-stage biopharmaceutical enterprise Disc Medicine announced the pricing of an upsized underwritten public offering, securing 450 million USD in gross proceeds.The Massachusetts-based company agreed to sell 6 milli…

October 20, 2026 – United Kingdom-based Silence Therapeutics agreed to be acquired by Germany-based Merck KGaA in an all-cash transaction valuing the biopharmaceutical company's equity at approximately 1.3 billion USD.The definitive agreeme…
-1788993670446_320.webp)
September 10, 2026 – Shares of Roivant Sciences advanced significantly this week, clearing the 41 USD threshold following favorable clinical updates.Institutional asset managers are actively recalibrating the biotechnology holding company a…

September 9, 2026 – Shares of Max Healthcare Institute advanced 4.5 percent during Wednesday trading, supported by sustained institutional accumulation across the Indian healthcare sector.Asset managers are actively pricing in the successfu…

On May 4, 2026, Pfizer Inc. remains in focus as Pfizer stock continues to trade sluggishly, raising questions about its future direction. The spotlight is firmly on whether Pfizer stock can regain momentum. Pfizer Stock: Waiting Game or H…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated: